Long-term survival in metastatic melanoma patients treated with sequential biochemotherapy: report of a Phase II study. | Cancer Invest;24(5): 474-8, 2006. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Long-term survival in metastatic melanoma patients treated with sequential biochemotherapy: report of a Phase II study.

Neri, B; Vannozzi, L; Fulignati, C; Pantaleo, P; Pantalone, D; Paoletti, C; Perfetto, F; Turrini, M; Mazzanti, R.

Affiliation

Neri B; Department of Internal Medicine-Centre of Experimental and Clinical Oncology, Postgraduate School of Oncology, University of Florence, Italy. bruno.neri@unifi.it

Cancer Invest ; 24(5): 474-8, 2006.

Article in En | MEDLINE | ID: mdl-16939954

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Agents, Alkylating / Immunologic Factors / Melanoma Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Invest Year: 2006 Document type: Article Affiliation country: Italia Country of publication: Reino Unido

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Agents, Alkylating / Immunologic Factors / Melanoma Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Invest Year: 2006 Document type: Article Affiliation country: Italia Country of publication: Reino Unido